Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I suspect and expect that the BOD will come out with a statement

stating that due to Shareholder's refusal to approve the recommended Reverse Split, the only remaining options for the Company are to take actions which will now impact Shareholders in an even more negative way.

In other words, the blame falls to Shareholders themselves for any harm that comes to Shareholder Equity via changes to our Corporate or Capitalization structure.

There are certain important numbers which I believe really only concern these folks, and those have nothing to do with company performance or the patents; but everything to do with behavioral statistics.

4
May 04, 2016 02:43PM
1
May 04, 2016 02:45PM
Share
New Message
Please login to post a reply